Experimental group:lobaplatin
Sponsors
Sun Yat-Sen University Cancer Center, Shanghai Jiao Tong University Affliated Sixth People's Hospital
Conditions
Cervical cancerNasopharyngeal carcinoma
Phase 3
A prospective, parallel-controlled, randomized, open-label, multicenter, phase III clinical trial of lobaplatin vs cisplatin combined with IMRT concurrent chemoradiotherapy for locally advanced and low-risk nasopharyngeal carcinoma
Active, not recruitingChiCTR1900021536
Start: 2019-03-01Updated: 2019-03-04
A study for comparing efficacy and safety of lobaplatin versus cisplatin concurrent chemoradiotherapy for cervical cancer
Active, not recruitingChiCTR2000035449
Start: 2020-10-01Updated: 2020-08-17